Loading...
(1) What is HOPE?
HOPE全称叫做全球益生菌/益生元循证数据库，英文名Global Evidence-based Database for Health Outcomes of Pro/PrEbiotics。 我们从Health Outcomes of Pro/PrEbiotics里面取了四个英文字母，就组成了HOPE。
(2) Where does the name HOPE come from?
The name HOPE has two origins.
First of all, I have to thank one person, that is, Sister Yan Ning, who is currently working at SMART (that is, Shenzhen Academy of Medical Sciences). Together with her, I co-edited a journal of the Department of Biology at Tsinghua University called Honeysuckle. She is a master of publicity, and the English name SMART has inspired me a lot.
Secondly, I want to thank the AI. I asked the AI: I also want to have a loud name like SMART, to do a global probiotic/prebiotic evidence-based database, what do you recommend? I asked a dozen AIs, and finally Google's Gemini gave me a hint. It says you can add Health Outcomes of Pro/PrEbiotics, which can make up a HOPE. That's how the name HOPE came about.
(3) What is the original intention of HOPE?
First, because I am often asked to recommend products such as prebiotics and probiotics, to be honest, I want to have a reliable recommendation supported by objective data.
Second, the current probiotic/prebiotic market is not mature enough, and the relevant industry standards and regulatory systems are also relatively lacking.
Third, start from the ability of a warm-hearted team. At present, our "Warm Hearted Daily" is doing quite well, and on this basis, I think we can develop such a database as HOPE. Of course, there are also many expert friends and industry friends who have been encouraging us, and we hope that the enthusiastic team can do something similar.
Based on the above three considerations, we will launch HOPE.
(4) What do you want to make HOPE?
First of all, we want to capture the basic information of global probiotics/prebiotics, such as raw materials, products, scientific literature, patent information, and a series of related test reports.
On this basis, we will do some ratings, lists or recommendations from an objective point of view. In the future, when someone asks Mr. Warm-hearted, "Do you have any recommendations?" I will basically only recommend the ingredients or products that are included in HOPE.
Of course, because we are neither a standards body nor a regulatory body, this HOPE is essentially a service platform.
In addition, we also hope to open this system to the industry in the future, and help willing companies or brands to be a small HOPE and disclose their own academic research, clinical confirmation or other information.
In the future, it is expected that HOPE will develop to a certain extent and make a little contribution to the standard formulation and supervision of the probiotic/prebiotic industry based on sufficient massive data.
Conflict of Interest Statement
Conflict of Interest Statement
He is the co-founder and executive editor of iMeta journal, holds positions in professional institutions such as national societies, and serves as a university chair professor.
However, readers should be reminded that the company he founded and mainly works in, Beijing Warm Heart Biotechnology Research Institute Co., Ltd., is a for-profit commercial organization, and he also serves as chairman and director of this company and a number of affiliated companies.
In addition, he is also a consultant or consultant officially employed by Shanghai Pharmaceutical, H&H Group, Mengniu Group and other enterprises, and provides strategy, product and other consulting services for many other enterprises.
Mr. Warmheart benefits from the above-mentioned for-profit organizations through shareholdings, salaries, dividends and consulting fees, and although he always wants to uphold a scientific, objective and impartial attitude at the time of writing, the following conflicts of interest may inevitably exist due to the above reasons:
- Loss of rigor, objectivity, and professionalism in science communication due to commercial motives.
- Emphasis is placed on the products and services of interested companies and other potential options are neglected.
- Emphasize the strengths of the stakeholder companies and downplay their weaknesses.
In order to avoid and reduce the non-objectivity caused by conflicts of interest, Mr. Warmheart will take the following measures:
- This statement is made public, clearly indicating the relationship between the interested companies.
- Evaluate all organizations, including stakeholder companies, objectively and fairly.
- Readers are encouraged to make criticisms and suggestions and to improve them.
When reading Mr. Warmheart's articles, readers should pay attention to understanding his business background, and maintain rational judgment and critical thinking.